These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21962138)

  • 1. Early anti-angiogenic proteins expression in amniotic fluid of twin fetuses.
    Wang CN; Chen JY; Chao AS; Cheng PJ; Chang SD; Wang TH
    Twin Res Hum Genet; 2011 Oct; 14(5):452-6. PubMed ID: 21962138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in amniotic fluid levels of multiple anti-angiogenic proteins before development of preeclampsia and intrauterine growth restriction.
    Wang CN; Chang SD; Peng HH; Lee YS; Chang YL; Cheng PJ; Chao AS; Wang TH; Wang HS
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1431-41. PubMed ID: 20080845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexplained fetal death is associated with increased concentrations of anti-angiogenic factors in amniotic fluid.
    Chaiworapongsa T; Romero R; Kusanovic JP; Savasan ZA; Kim SK; Mazaki-Tovi S; Vaisbuch E; Ogge G; Madan I; Dong Z; Yeo L; Mittal P; Hassan SS
    J Matern Fetal Neonatal Med; 2010 Aug; 23(8):794-805. PubMed ID: 20199197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoglin in amniotic fluid as a risk factor for the subsequent development of bronchopulmonary dysplasia.
    Kim SK; Romero R; Savasan ZA; Xu Y; Dong Z; Lee DC; Yeo L; Hassan SS; Chaiworapongsa T
    Am J Reprod Immunol; 2013 Feb; 69(2):105-23. PubMed ID: 23279628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia.
    Staff AC; Braekke K; Johnsen GM; Karumanchi SA; Harsem NK
    Am J Obstet Gynecol; 2007 Aug; 197(2):176.e1-6. PubMed ID: 17689641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First trimester serum angiogenic/anti-angiogenic status in twin pregnancies: relationship with assisted reproduction technology.
    Sánchez O; Llurba E; Marsal G; Domínguez C; Aulesa C; Sánchez-Durán MA; Goya MM; Alijotas-Reig J; Carreras E; Cabero L
    Hum Reprod; 2012 Feb; 27(2):358-65. PubMed ID: 22116949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated placenta growth factor levels in the early second-trimester amniotic fluid are associated with preterm delivery.
    Lee H; Kwon JY; Lee S; Kim SJ; Shin JC; Park IY
    J Matern Fetal Neonatal Med; 2016 Oct; 29(20):3374-8. PubMed ID: 26634962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
    Moore Simas TA; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Maynard SE
    J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1038-48. PubMed ID: 24066977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gestational angiogenic biomarker patterns in high risk preeclampsia groups.
    Maynard SE; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Moore Simas TA
    Am J Obstet Gynecol; 2013 Jul; 209(1):53.e1-9. PubMed ID: 23517919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble endoglin for the prediction of preeclampsia in a high risk cohort.
    Maynard SE; Moore Simas TA; Bur L; Crawford SL; Solitro MJ; Meyer BA
    Hypertens Pregnancy; 2010; 29(3):330-41. PubMed ID: 20670156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.
    Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2672-9. PubMed ID: 17426083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
    Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
    Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal imbalance between pro-angiogenic and anti-angiogenic factors in HIV-infected women with pre-eclampsia.
    Govender N; Naicker T; Moodley J
    Cardiovasc J Afr; 2013 Jun; 24(5):174-9. PubMed ID: 24217170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating angiogenic factors in monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome and selective intrauterine growth restriction.
    Yinon Y; Ben Meir E; Berezowsky A; Weisz B; Schiff E; Mazaki-Tovi S; Lipitz S
    Am J Obstet Gynecol; 2014 Feb; 210(2):141.e1-7. PubMed ID: 24055584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion.
    Stepan H; Geipel A; Schwarz F; Krämer T; Wessel N; Faber R
    Am J Obstet Gynecol; 2008 Feb; 198(2):175.e1-6. PubMed ID: 18226617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadd45α as an upstream signaling molecule of p38 MAPK triggers oxidative stress-induced sFlt-1 and sEng upregulation in preeclampsia.
    Luo X; Yao ZW; Qi HB; Liu DD; Chen GQ; Huang S; Li QS
    Cell Tissue Res; 2011 Jun; 344(3):551-65. PubMed ID: 21519896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and foetal angiogenic imbalance in congenital heart defects.
    Llurba E; Sánchez O; Ferrer Q; Nicolaides KH; Ruíz A; Domínguez C; Sánchez-de-Toledo J; García-García B; Soro G; Arévalo S; Goya M; Suy A; Pérez-Hoyos S; Alijotas-Reig J; Carreras E; Cabero L
    Eur Heart J; 2014 Mar; 35(11):701-7. PubMed ID: 24159191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
    Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.